AR106716A1 - ANTI-FACTOR ANTIBODIES AND CONJUGATES - Google Patents

ANTI-FACTOR ANTIBODIES AND CONJUGATES

Info

Publication number
AR106716A1
AR106716A1 ARP160103279A ARP160103279A AR106716A1 AR 106716 A1 AR106716 A1 AR 106716A1 AR P160103279 A ARP160103279 A AR P160103279A AR P160103279 A ARP160103279 A AR P160103279A AR 106716 A1 AR106716 A1 AR 106716A1
Authority
AR
Argentina
Prior art keywords
conjugates
factor antibodies
factor
antibodies
nucleic acid
Prior art date
Application number
ARP160103279A
Other languages
Spanish (es)
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of AR106716A1 publication Critical patent/AR106716A1/en

Links

Abstract

Anticuerpos anti-Factor D y conjugados y métodos de uso de estos. Ácido nucleico, célula huésped, composición farmacéutica y método de tratamiento.Anti-Factor D and conjugate antibodies and methods of use thereof. Nucleic acid, host cell, pharmaceutical composition and treatment method.

ARP160103279A 2015-10-30 2016-10-27 ANTI-FACTOR ANTIBODIES AND CONJUGATES AR106716A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562249166P 2015-10-30 2015-10-30

Publications (1)

Publication Number Publication Date
AR106716A1 true AR106716A1 (en) 2018-02-14

Family

ID=61247569

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP160103279A AR106716A1 (en) 2015-10-30 2016-10-27 ANTI-FACTOR ANTIBODIES AND CONJUGATES

Country Status (1)

Country Link
AR (1) AR106716A1 (en)

Similar Documents

Publication Publication Date Title
BR112016022814A8 (en) pharmaceutical composition and its method of preparation, nucleic acid, and medical device or medical kit
CL2018001000A1 (en) Antibodies and antibody conjugates and anti-egfr drug.
BR112018003269A2 (en) anti-dll3 drug-antibody conjugates and methods of use
AR101845A1 (en) ANTI-HER2 AND IMMUNOCUSED ANTIBODIES
BR112017009728A2 (en) isolated antibodies, isolated nucleic acid, vector, host cell, method for producing antibody, composition, uses of an antibody and methods of treating a disorder
AR093377A1 (en) ANTI-NOTCH ANTIBODIES AND ANTIBODY-FARMACO CONJUGATES
BR112018005937A2 (en) affinity oligonucleotide conjugates and uses of these
BR112017024384A2 (en) bacteria modified to reduce hyperphenylalaninemia
EA201790248A1 (en) MEDIA-ANTIBODY COMPOSITIONS AND METHODS FOR THEIR RECEIVING AND APPLICATION
BR112016017986A2 (en) isolated antibodies, isolated nucleic acid, host cell, methods of producing an antibody, treating cancer, treating a disease and detecting human jagged1 in a biological sample, immunoconjugate, pharmaceutical formulation and antibody use
BR112017025564A2 (en) anti-ctla-4 antibodies and methods of use
BR112019011582A2 (en) antibodies and their methods of use
BR112016015958A2 (en) RNA-GUIDED GENE DRIVES
AR090903A1 (en) ANTI-PMEL ANTIBODIES AND IMMUNOCADES17
BR112017011326A2 (en) antibody, nucleic acid, vector, host cell, method for producing antibody, immunoconjugate, pharmaceutical composition, uses of the antibody, methods for treating or slowing the progression of cell proliferative disorder and for enhancing immune function
UA117364C2 (en) Amatoxin derivatives
EA201690492A1 (en) CELLULATING CONJUGATES AND METHODS FOR THEIR APPLICATION
EA201692425A1 (en) MODIFIED BIOPOLYMERS AND METHODS OF THEIR PRODUCTION AND USE
EA201690529A1 (en) METHODS OF MODIFICATION OF CELL-HOST
BR112016015105A2 (en) VAR2CSA-DRUG CONJUGATES
AR093446A1 (en) ANTIHEMAGLUTININE ANTIBODIES AND METHODS OF USE
EA201792080A1 (en) HUMANIZED ANTI-C1S ANTIBODIES AND METHODS OF THEIR APPLICATION
BR112016008477A2 (en) BODIES, NUCLEIC ACID, HOST CELL, METHOD OF PRODUCING AN ANTIBODY, IMMUNOCONJUGATE, PHARMACEUTICAL FORMULATION AND USES OF THE ANTIBODY
BR112017016897A2 (en) fungal strains and methods of use
BR112018010279A2 (en) new anti-emr2 antibodies and methods of use

Legal Events

Date Code Title Description
FB Suspension of granting procedure